You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. STTR Phase I: Nanoparticulate metal oxide electrodes for fast charging lithium ion batteries

    SBC: Battery Streak, Inc.            Topic: EN

    The broader impact/commercial potential of this project is to develop and commercialize a fast charging battery which offers better safety with long cycle life compared to today’s lithium (Li)-ion batteries. In traditional batteries, fast charging can cause the battery to become dangerously hot (more than 60°C/140°F) and reduce the life of the battery to one or two charges. The proposed batter ...

    STTR Phase I 2021 National Science Foundation
  2. STTR Phase I: Discovery and Development of Macrocyclic Peptide Inhibitors of SARS-COV-2 Spike Protein for the Treatment of COVID-19

    SBC: PHENOTARGET BIOSCIENCES, INC.            Topic: PT

    The broader impact /commercial potential of this Small Business Technology Transfer (STTR) Phase I project lies in the discovery and development of first-in-class therapeutics as an anti-viral treatment of COVID-19 viral infection. Within the proposed studies, cyclic peptide-based novel, effective anti-viral drug candidates will be identified. Compared to small molecule-based drugs, peptides will ...

    STTR Phase I 2021 National Science Foundation
  3. STTR Phase I: Harnessing the power of introns for safe and effective therapeutics and genomic screening

    SBC: TARTAN LLC            Topic: PT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project will be the development of a safe and effective treatment for a devastating form of pediatric epilepsy called Dravet syndrome. Dravet syndrome is an inherited disease that is caused by mutations in an ion channel called SCN1A. Gene therapy is an approach that involves replacement of mutated DN ...

    STTR Phase I 2021 National Science Foundation
  4. STTR Phase I: Toward the first novel multi-sensor smart wearable system for hot flash detection

    SBC: Lisa Health Inc.            Topic: MD

    The broader impact/commercial potential of this Small Business Technology Transfer Program (STTR) Phase I project is to help women undergoing menopause. Most women undergo menopause, a complex biobehavioral life stage that spans one-third of their life, frequently accompanied by a complex array of symptoms affecting their health, quality of life, relationships, and productivity. The most common an ...

    STTR Phase I 2021 National Science Foundation
  5. STTR Phase I: Carbon Sequestration & Waste Management for College Campuses & Larger Facilities

    SBC: CARIBOU BIOFUELS, INC.            Topic: ET

    The broader impact/commercial potential of this Small Business Technology Transfer Research Phase I project is to use waste to produce clean, green energy. The proposed technology diverts waste material from landfills while sequestering carbon and can be used in many other industries such as food waste, forestry biomass and disaster relief. For example, wildfires are becoming an annual threat that ...

    STTR Phase I 2021 National Science Foundation
  6. STTR Phase I: On-chip integration of sample preparation and monitoring with dielectrophoretic cell isolation

    SBC: CYTORECOVERY, INC.            Topic: BM

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is a platform to isolate cells based on their biophysical properties. The platform will help isolate cells that are not abundant and enable study of their role in biological function and diseases such as cancer. Specifically, a single chip platform will carry out sample preparation, manipulati ...

    STTR Phase I 2021 National Science Foundation
  7. STTR Phase I: Novel size-changing, gadolinium-free contrast agent for magnetic resonance angiography

    SBC: NanoXort            Topic: BM

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is improved diagnosis of cardiovascular disease, the top cause of death globally, taking about 18 million lives each year. The proposed work will develop a contrast agent that improves the diagnostic value of magnetic resonance angiograms (MRA), by enhancing images of the vascular system, and ...

    STTR Phase I 2021 National Science Foundation
  8. STTR Phase I: A system for collection, transportation and accurate analysis of RNA virus specimens

    SBC: KEPLER DIAGNOSTICS, INC.            Topic: BM

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to support a testing device for collection, transportation and diagnosis of certain viral infections, such as hepatitis C virus (HCV), human immunodeficiency virus (HIV) and measles. Recent viral outbreaks of measles, Ebola, Zika, SARS-CoV, and the COVID-19 pandemic have illustrated the nee ...

    STTR Phase I 2021 National Science Foundation
  9. STTR Phase I: Haptics in Telerobotics for Improved Remote Dexterity

    SBC: Tangible Research Inc.            Topic: R

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to advance haptics - electromechanical systems that operate through the sense of touch. This technology may improve the performance of telemanipulation systems, making the operation similar to that of bare hands, and advance a new generation of robotic tools allowing humans to remotely feel ...

    STTR Phase I 2021 National Science Foundation
  10. STTR Phase I: A kinetic and conformation based platform for targeting G-protein coupled receptors

    SBC: Seven Biosciences, Inc.            Topic: PT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is to enable the discovery of new therapeutics targeting G protein-coupled receptors (GCPRs). GPCRs are expressed in nearly every organ system, are accessible due to their location on the membrane and potential to elicit almost every signaling pathway. Drugs targeting GPCRs make up 35% of all ...

    STTR Phase I 2021 National Science Foundation
US Flag An Official Website of the United States Government